CMS is proposing to verify certain drug prices reported by manufacturers through an annual Medicaid Drug Price Verification Survey. By verifying drug prices and publishing non-proprietary information about the drug prices, the survey would increase public transparency for high
Newsroom homepage
Biden-Harris Administration Announces Proposal to Advance Prescription Drug Transparency in Medicaid
The Centers for Medicare & Medicaid Services’ (CMS’) proposed rule seeks to advance policies to promote efficient operation of the Medicaid Drug Rebate Program (MDRP). This includes proposed policies to implement new statutory authorities included in the Medicaid Services
Today, the Centers for Medicare & Medicaid Services (CMS) is providing an at-a-glance summary of news from around the agency:
CMS Continues to Provide Timely Updates to Providers, Partners, and the Public Related to the End of the COVID-19 Public Health Emergency (PHE)
May
Overview: A Long-awaited Guide to Help Schools Give Care to Children in Medicaid and CHIP
The Centers for Medicare & Medicaid Services (CMS) is releasing Delivering Service in School-Based Settings: A Comprehensive Guide to Medicaid Services and Administrative Claiming. Develo